Efficacy, safety and tolerability of natalizumab in Turkish multiple sclerosis patients with high disease activity: a prospective, multicentre study
| dc.contributor.author | Turan, O. F. | |
| dc.contributor.author | Demirci, N. O. | |
| dc.contributor.author | Akman-Demir, G. | |
| dc.contributor.author | Agan, K. | |
| dc.contributor.author | Gunal, D. | |
| dc.contributor.author | Us, O. | |
| dc.contributor.author | Taskapilioglu, O. | |
| dc.contributor.author | Boz, C. | |
| dc.contributor.author | Terzi, M. | |
| dc.contributor.author | Onar, M. | |
| dc.contributor.author | Aydin-Gungor, H. | |
| dc.contributor.author | Turk-Boru, U. | |
| dc.contributor.author | Soysal, A. | |
| dc.contributor.author | Petek-Balci, B. | |
| dc.contributor.author | Turkoglu, R. | |
| dc.contributor.author | Tutuncu, M. | |
| dc.contributor.author | Saip, S. | |
| dc.contributor.author | Eraksoy, M. | |
| dc.contributor.author | Siva, A. | |
| dc.contributor.author | Dib, H. | |
| dc.date.accessioned | 2021-03-03T15:58:56Z | |
| dc.date.available | 2021-03-03T15:58:56Z | |
| dc.identifier.citation | Eraksoy M., Akman-Demir G., Agan K., Gunal D., Us O., Saip S., Demirci N. O. , Tutuncu M., Turan O. F. , Taskapilioglu O., et al., "Efficacy, safety and tolerability of natalizumab in Turkish multiple sclerosis patients with high disease activity: a prospective, multicentre study", 19th World Congress of Neurology, Bangkok, Tayland, 24 - 30 Ekim 2009, cilt.285 | |
| dc.identifier.other | av_41cf63c8-c6d8-4773-96ae-3ef0480696f6 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/47963 | |
| dc.identifier.uri | https://doi.org/10.1016/s0022-510x(09)70798-1 | |
| dc.language.iso | eng | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Klinik Tıp | |
| dc.subject | NEUROSCIENCES | |
| dc.subject | Sinirbilim ve Davranış | |
| dc.subject | Yaşam Bilimleri (LIFE) | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | KLİNİK NEUROLOJİ | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | Nöroloji | |
| dc.subject | Yaşam Bilimleri | |
| dc.subject | Temel Bilimler | |
| dc.title | Efficacy, safety and tolerability of natalizumab in Turkish multiple sclerosis patients with high disease activity: a prospective, multicentre study | |
| dc.type | Bildiri | |
| dc.contributor.department | İstanbul Üniversitesi , , | |
| dc.identifier.volume | 285 | |
| dc.contributor.firstauthorID | 136435 |
Bu öğenin dosyaları:
| Dosyalar | Boyut | Biçim | Göster |
|---|---|---|---|
|
Bu öğe ile ilişkili dosya yok. |
|||
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Bildiri [64839]